The Chinese trial showed the antiviral remdesivir did not improve patients’ condition or reduce the pathogen’s presence in the bloodstream, the report said.
It’s going to take a lot for me to begin trusting Chinese data.
Watch now as the MSM and Libs say that we can’t trust a thing out of China...
“The paper said that researchers studied 237 patients, giving the drug to 158 and comparing their progress with the remaining 79. The story indicated that the drug showed significant side effects in some, with 18 patients taken off it.” - Mark DeCambre; AskNewswires@dowjones.com
However, premature cremation was 100% effective in flattening the curve
We desperately need an effective therapeutic. Something that works is a potential ticket out of this mess.
I presume China’s orginal plan isn’t working. Gilead applied for a Chinese patent for remdesivir in 2016 and are still waiting for the patent. Meanwhile, the Chinese made a copycat version. If they unleashed SAR-Cov-2 (COVID19) into the general populace I have to assume they had hoped to generate a windfall with the only PATENTED version of remdesivir.